drugset / Trial / NCT01045902
BAY12-8039, iv/Oral Pulmonary Abscess/Aspiration Pneumonia
RandomizedParallel-groupOpen-labelTreatment
Summary
The purpose of this trial is to determine the efficacy and safety of Moxifloxacin in comparison to Sulbactam/Ampicillin in the treatment of pulmonary abscesses and aspiration pneumonia.
Timeline
- Start
- 2001-02
- Primary completion
- —
- Completion
- 2005-01
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Comparator | Ampicillin | Unknown | — | Intravenous |
| Subject | Moxifloxacin | Small molecule | 400 mg | Intravenous |
| Comparator | Sulbactam | Small molecule | — | Intravenous |